A COST-UTILITY ANALYSIS OF PROLONGED-RELEASE TACROLIMUS RELATIVE TO IMMEDIATE-RELEASE TACROLIMUS AND CICLOSPORIN IN LIVER TRANSPLANT RECIPIENTS IN THE UK

被引：0
|
作者：
Muduma, G. [1 ]
Odeyemi, I. A. [1 ]
Pollock, R. F. [2 ]
机构：
[1] Astellas Pharma Europe Ltd, Chertsey, England
[2] Ossian Hlth Econ & Commun GmbH, Basel, Switzerland
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2218
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI37
引用
收藏
页码：A628 / A629
页数：2
相关论文
共 50 条
  • [1] A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK
    Muduma, Gorden
    Odeyemi, Isaac
    Pollock, Richard F.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (10) : 995 - 1002
  • [2] SYSTEMATIC LITERATURE REVIEW, META-ANALYSIS AND INDIRECT TREATMENT COMPARISON OF PROLONGED-RELEASE TACROLIMUS RELATIVE TO CICLOSPORIN AND IMMEDIATE-RELEASE TACROLIMUS AS THE PRIMARY IMMUNOSUPPRESSIVE REGIMEN IN LIVER TRANSPLANT RECIPIENTS
    Muduma, G.
    Saunders, R.
    Odeyemi, I. A.
    Pollock, R. F.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A222 - A222
  • [3] Cost Effectiveness of Prolonged-Release Tacrolimus in Liver Transplant Recipients
    Vitale, Alessandro
    Boccagni, Patrizia
    Burra, Patrizia
    Angeli, Paolo
    Zanus, Giacomo
    Neri, Daniele
    Cillo, Umberto
    [J]. TRANSPLANTATION, 2016, 100 : S182 - S183
  • [4] EVALUATING THE COST-EFFECTIVENESS OF PROLONGED-RELEASE TACROLIMUS RELATIVE TO IMMEDIATE-RELEASE TACROLIMUS IN LIVER TRANSPLANT PATIENTS BASED ON DATA FROM ROUTINE CLINICAL PRACTICE
    Maduma, G.
    Odeyerni, I. A.
    Pollock, R. F.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A626 - A626
  • [5] Evaluating the Cost-Effectiveness of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus in Liver Transplant Patients Based on Data from Routine Clinical Practice
    Muduma G.
    Odeyemi I.
    Pollock R.F.
    [J]. Drugs - Real World Outcomes, 2016, 3 (1) : 61 - 68
  • [6] Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation
    Rubik, Jacek
    Debray, Dominique
    Iserin, Franck
    Vondrak, Karel
    Sellier-Leclerc, Anne-Laure
    Kelly, Deirdre
    Czubkowski, Piotr
    Webb, Nicholas J. A.
    Riva, Silvia
    D'Antiga, Lorenzo
    Marks, Stephen D.
    Rivet, Christine
    Toenshoff, Burkhard
    Kazeem, Gbenga
    Undre, Nasrullah
    [J]. PEDIATRIC TRANSPLANTATION, 2019, 23 (04)
  • [7] Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study
    Gonzalez-Vilchez, Francisco
    Delgado, Juan F.
    Palomo, Jesus
    Mirabet, Sonia
    Diaz-Molina, Beatriz
    Almenar, Luis
    Arizon, Jose M.
    Rangel-Sousa, Diego
    Perez-Villa, Felix
    Garrido, Iris P.
    de la Fuente, Luis
    Gomez-Bueno, Manuel
    Sanz, Maria L.
    Crespo-Leiro, Maria G.
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (06) : 1994 - 2001
  • [8] Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus
    Lauzurica, Ricardo
    Morales, Jose M.
    van Hooff, Johannes
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 (01) : 48 - 55
  • [9] Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence
    Muduma, Gorden
    Odeyemi, Isaac
    Smith-Palmer, Jayne
    Pollock, Richard F.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 391 - 399
  • [10] BUDGET IMPACT OF SWITCHING FROM AN IMMEDIATE-RELEASE TO A PROLONGED-RELEASE FORMULATION OF TACROLIMUS IN RENAL TRANSPLANT RECIPIENTS IN THE UK BASED ON DIFFERENCES IN ADHERENCE
    Pollock, R. F.
    Smith-Palmer, J.
    Odeyemi, I. A.
    Muduma, G.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A631 - A631
12345